DAPP1 blocking peptide product blog
Tags: Blocking Peptide; DAPP1; DAPP1 blocking peptide;
The DAPP1 dapp1 (Catalog #MBS9222529) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The DAPP1 dapp1 product has the following accession number(s) (GI #51317293) (NCBI Accession #Q9UN19.1) (Uniprot Accession #Q9UN19). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May act as a B-cell-associated adapter that regulates B- cell antigen receptor (BCR)-signaling downstream of PI3K.
Cellular Location: Cytoplasm. Membrane; Peripheral membrane protein. Note: Membrane-associated after cell stimulation leading to its translocation. Tissue Location: Highly expressed in placenta and lung, followed by brain, heart, kidney, liver, pancreas and skeletal muscle. Expressed by B-lymphocytes, but not T-lymphocytes or nonhematopoietic cells. Carcinoma, Hepatocellular, Hepatomegaly, Hypertrophy, Inflammation, Liver Neoplasms, Necrosis are some of the diseases may be linked to DAPP1 Antibody (C-term) Blocking Peptide. The following patways have been known to be associated with this gene. Blood, Liver, Lymph, Lymph Node, Spleen tissues are correlated with this protein. DAPP1 also interacts with the following gene(s): LCK, LYN, SRC.